Menu

Search

Ayako Miyashita

Ayako Miyashita

Adjunct Professor of Public Policy and Social Welfare, University of California, Los Angeles
Ayako Miyashita Ochoa is an Adjunct Professor at the UCLA Luskin School of Public Affairs, Department of Social Welfare. She serves as Co-Director of Luskin’s new Center, UCLA Hub for Health Intervention, Policy and Practice (UCLA HHIPP). UCLA HHIPP’s mission is to co-create research that informs policy and practice and addresses intersecting oppressions in order to improve community health. As Co-Director for the Southern California HIV/AIDS Policy Research Center (SCHPRC), Professor Miyashita collaborates on interdisciplinary research with community and academic partners to bring the most relevant and timely evidence to bear on California’s efforts to develop and maintain efficient, cost-effective, and accessible programs and services to people living with or at risk for HIV, viral hepatitis, sexually transmitted infections and overdose. Her research interests focus on HIV and other related health disparities at the intersection of race/ethnicity, sexual and gender identity, and migrant status.

In addition to serving as a faculty representative to the LGBTQ Affairs Committee at UCLA, Professor Miyashita is Co-Director of the Policy Impact Core for UCLA Center for HIV Identification, Prevention and Treatment Services (CHIPTS) as well as a Faculty Affiliate of UCLA California Center for Population Research (CCPR). Her teaching includes courses at UCLA Luskin, including LGBTQ Health, Law and Public Policy, Education and the Law, and Social Welfare Law and Ethics—a newly designed course.

Prior to joining the faculty at UCLA Luskin, Professor Miyashita directed the Los Angeles HIV Law and Policy Project, a legal services collaborative dedicated to addressing the unmet legal needs of primarily low-income people living with HIV (“PLWH”) in Los Angeles County. As a Director in the Clinical and Experiential Learning Department at UCLA School of Law, Professor Miyashita taught courses on the attorney-client relationship, client interviewing and counseling, and HIV law and policy. As the HIV Law and Policy Fellow at the Williams Institute in 2013-2015, her research included studies on HIV criminalization, unmet legal needs of PLWH in addition to issues related to HIV privacy and confidentiality.

In her legal practice, Professor Miyashita provided direct legal services to low-income clients living with HIV in the San Francisco Bay Area and Los Angeles counties. This included assisting clients in obtaining disability benefits and other supports necessary to live independently. Her legal expertise runs a broad spectrum of public benefits including income support, health coverage, and other support services necessary for individuals living with disabilities. Professor Miyashita regularly provides training and education to clients, advocates, health and social service providers, and legislative and policymaking bodies.

Professor Miyashita earned her Juris Doctor from U.C. Berkeley School of Law and was admitted to the State Bar of California in 2009.

1 

Economy

China's Deflationary Woes: CPI and PPI Signal Persistent Economic Challenges

Chinas Consumer Price Index (CPI) dropped 0.1% from year-ago in Chinas Consumer Price Index (CPI) declined 0.1% from a year ago in March 2025, less than Februarys decline of 0.7%. That was lower than an expected rise of...

Trump's Tariff U-Turn: 90-Day Reprieve for Most, China Still in the Crosshairs

On April 2025, Donald Trump announced a 90-day tariff relief for the majority of nations, a dazzling about-turn after imposing them, out of fear of market volatility. This was at a time when global markets were in...

[Editorial Cartoon] “Tariff Chicken Game” – U.S. and China Speed Toward Economic Catastrophe

Amid rising tensions in the U.S.-China trade war, this weeks editorial cartoon depicts a dramatic chicken game scenario, where two economic superpowers appear locked in a collision course with potentially devastating...

Trade War Escalates: China Fires Back with 84% Tariff on US Goods

China escalated the stakes of the trade war with America by imposing an 84% tariff on American products as a retaliatory measure to President Trumps recent tariffs on Chinese products. The retaliatory tariff which...

China's Treasury "Nuclear Option": Bluff or Reality?

If China were to sell its $761 billion in U.S. Treasury bonds, the immediate effects would be higher U.S. Treasury yields, which would rise by 30 to 60 basis points, raising the borrowing cost and cutting economic growth....

Politics

IRS Chief to Resign Amid Controversial Tax Data Sharing Deal with Homeland Security

The acting head of the U.S. Internal Revenue Service (IRS), Melanie Krause, is set to resign following a controversial agreement to share undocumented immigrants tax data with the Department of Homeland Security (DHS),...

Ken Paxton to Challenge Sen. John Cornyn in 2026 Texas GOP Primary

Texas Attorney General Ken Paxton has announced his bid to unseat fellow Republican Senator John Cornyn in the 2026 GOP primary. Speaking on Fox News The Ingraham Angle, Paxton declared his intention to bring stronger...

Trump Slams TSMC Subsidy, Threatens 100% Tax Without U.S. Manufacturing

President Donald Trump criticized the Biden administration for awarding a $6.6 billion subsidy to Taiwan Semiconductor Manufacturing Company (TSMC), arguing that semiconductor giants like TSMC do not need government...

Trump Moves to Block State Climate Laws to Boost Fossil Fuel Industry

U.S. President Donald Trump signed a new executive order on Tuesday aimed at blocking state-level climate laws that restrict fossil fuel use and promote clean energy. This latest move underscores Trumps ongoing efforts to...

Pam Bondi to Lead DOJ Initiative Defending Second Amendment Rights

U.S. Attorney General Pam Bondi is set to spearhead a new Justice Department initiative aimed at protecting gun rights under the Second Amendment, according to a memo reviewed by Reuters. The memo outlines Bondis plan to...

Science

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

What are the chances an asteroid will impact Earth in 2032?

For a few days in mid-February, headlines around the world buzzed about the potential for an asteroid to hit the Earth in 2032 specifically, asteroid 2024 YR4. The chance of this impact rose to a high of 3.1 per cent on...

A new study reveals the structure of violent winds 1,300 light years away

The planet WASP-121b is extreme. Its a gas giant almost twice as big as Jupiter orbiting extremely close to its star50 times closer than the Earth does around the Sun. WASP-121b is so close to its star that tidal forces...

Technology

US Senators Question Microsoft and Google Over AI Cloud Partnerships

Two Democratic U.S. senators are pressing Microsoft (NASDAQ:MSFT) and Google (NASDAQ:GOOGL) for transparency over their cloud computing partnerships with leading artificial intelligence firms. Senators Elizabeth Warren of...

Telegram Fined $80K by Moscow Court for Extremist Content Refusal

A Moscow court has fined Telegram Messenger Inc. 7 million roubles (approximately $80,000) for refusing to remove content allegedly promoting extremist activities, according to Russian state news agency TASS. Court...

Samsung Posts Resilient Q1 Profit on Strong Chip and Smartphone Demand

Samsung Electronics reported a better-than-expected 0.2% drop in Q1 operating profit, reaching 6.6 trillion won ($4.49 billion), beating market forecasts of 5.1 trillion won. This resilience was driven by solid memory chip...

Meta Unveils Llama 4 Maverick and Scout, Boosts AI Ambitions

Meta Platforms (NASDAQ:META) has unveiled its latest AI modelsLlama 4 Maverick and Llama 4 Scoutcalling them its most advanced large language models (LLMs) to date. Designed as multimodal AI systems, they can process and...

Elon Musk’s Lawsuit Against OpenAI Heads to Jury Trial in 2026

Elon Musks high-profile lawsuit against OpenAI is set for a jury trial in spring 2026, as ruled by Judge Yvonne Gonzalez Rogers of the U.S. District Court for the Northern District of California. The case centers on Musks...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.